Home › Funds › Ceredex Value Advisors LLC › ELV

Ceredex Value Advisors LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Ceredex Value Advisors LLC reported holding 114,908 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$44.7M, representing 1.39% of its reported portfolio and ranking #4 among its reported holdings. Ceredex Value Advisors LLC has disclosed ELV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)114.91K sh
Reported value held$44.68M
Portfolio Weight1.39%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ceredex Value Advisors LLC's ELV position evolved

Ceredex Value Advisors LLC first disclosed a stake in ELV in Q2 2026 at 127,071 shares (US$49.1M). Across 2 filings, Ceredex Value Advisors LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 114,908 shares valued at US$44.7M — a reduction of -12,163 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 127.07K $49.14M New
Q3 2026 114.91K $44.68M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Ceredex Value Advisors LLC held ELV?

Ceredex Value Advisors LLC has disclosed ELV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Ceredex Value Advisors LLC's current position in ELV?

As of Q3 2026, Ceredex Value Advisors LLC holds 114.91K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $44.68M, representing 1.39% of its reported portfolio and ranking #4.

Has Ceredex Value Advisors LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), Ceredex Value Advisors LLC reduced its position in ELV.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.